24522-30-3,
2-cyano-N-[4-(trifluoromethyl)phenyl]acetamide,
2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide,
UNII-T4N584WTC2,
Acetamide, 2-cyano-N-[4-(trifluoromethyl)phenyl]-,
T4N584WTC2,
N-(4-trifluoromethylphenyl)cyanoacetamide,
Acetamide,2-cyano-N-[4-(trifluoromethyl)phenyl]-,
Acetamide, 2-cyano-N-(4-(trifluoromethyl)phenyl)-,
Leflunomide impurity H [EP],
Leflunomide Impurity H,
AC1MXZCU,
p-Acetotoluidide, 2-cyano-alpha,alpha,alpha-trifluoro-,
SCHEMBL1498374,
CTK4F3829,
DTXSID50179275,
JBNCFFDGYDZEEN-UHFFFAOYSA-N,
4'-trifluoromethyl-cyanoacetanilide,
CS-M2760,
KS-00000N0J,
ZINC4105256,
BBL023189,
HTS001178,
MFCD05669245,
STL072961,
AKOS000166723,
Leflunomide impurity, 2-cyano-acetic acid-(4'-trifluoromethyl)-anilide- [USP],
BS-3667,
MCULE-5886830267,
MS-0655,
AC-27036,
AK326675,
AB0109467,
H2574,
2-Cyano-N-(4-trifluoromethyl-phenyl)-acetamide,
2-cyano-n-[4-(trifluoromethyl) phenyl]acetamide,
N-[4-(Trifluoromethyl)phenyl]-2-cyanoacetamide,
SR-01000308182,
SR-01000308182-1,
C10H7F3N2O,
3-Bromo-4-chloro-5-nitropyridine,
ZINC04105256,
CID3823803,
C3217,